THE 60 GY IN 3 TO 5 FRACTIONS RECOMMENDATION FOR STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR STAGE I NON-SMALL CELL LUNG CANCER (NSCLC) IS OVERKILL: A PLEA FOR A INDIVIDUALISED DOSE PRESCRIPTION

被引：0
|
作者：
De Ruysscher, D. [1 ]
van Baardwijk, A. [2 ]
Tome, W. [3 ]
Bentzen, S. [3 ]
Wanders, S. [2 ]
Reymen, B. [2 ]
Borger, J. [2 ]
van Elmpt, W. [2 ]
Ollers, M. [2 ]
Lambin, P. [2 ]
机构：
[1] MUCM, Maastricht, Netherlands
[2] MAASTRO Clin, Maastricht, Netherlands
[3] Univ Wisconsin, Sch Med & Publ H, Madison, WI USA
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1044
引用
收藏
页码：S356 / S357
页数：2
相关论文
共 50 条
  • [31] Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): Is FDG-PET a predictor of outcome?
    Clarke, Katy
    Taremi, Mojgan
    Dahele, Max
    Freeman, Marc
    Fung, Sharon
    Franks, Kevin
    Bezjak, Andrea
    Brade, Anthony
    Cho, John
    Hope, Andrew
    Sun, Alexander
    RADIOTHERAPY AND ONCOLOGY, 2012, 104 (01) : 62 - 66
  • [32] Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC)
    Janssen, Stefan
    Kaesmann, Lukas
    Rudat, Volker
    Rades, Dirk
    ANTICANCER RESEARCH, 2016, 36 (02) : 825 - 828
  • [33] A Phase II Trial of Stereotactic Body Radiotherapy (SBRT) in Patients with Stage IV Oncogene Driven Non-Small Cell Lung Cancer ( NSCLC)
    Keane, F. K.
    Yeap, B. Y.
    Lin, J.
    Piotrowska, Z.
    Khandekar, M. J.
    Willers, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S94 - S94
  • [34] Stereotactic body radiotherapy for early stage non-small cell lung cancer
    Lagerwaard, F.
    LUNG CANCER, 2012, 77 : S9 - S10
  • [35] Evaluation of thoracic stereotactic body radiation therapy (SBRT) for stage IV non-small cell lung cancer (NSCLC).
    Wooten, Charles Eric
    Smith, Adam Joel Taylor
    Edwards, Jason M.
    Arnold, Susanne M.
    McGarry, Ronald
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [36] Real-World Data on Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiotherapy (SBRT)
    Van der Woude, L.
    Van der Wel, A.
    Van Bockel, L.
    Coremans, I.
    Dekker, A.
    Van Es, C.
    De Jaeger, K.
    Knol, H. P.
    Kolff, W.
    Koppe, F.
    Pomp, J.
    Schinagl, D.
    Spoelstra, F.
    Tissing-Tan, C.
    Ubbels, F.
    Vonk, E.
    Van der Voort-Van Zijp, N.
    Wiegman, E.
    Van der Geest, A.
    Reymen, B.
    Van Kampen, D.
    Damhuis, R.
    Belderbos, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S269 - S270
  • [37] Stereotactic single-dose radiotherapy of Stage I non-small-cell lung cancer (NSCLC)
    Hof, H
    Herfarth, KK
    Münter, M
    Hoess, A
    Motsch, J
    Wannenmacher, M
    Debus, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (02): : 335 - 341
  • [38] Stereotactic radiotherapy for operable stage I non-small cell lung cancer
    Martin, E.
    Nicolet, C.
    Boisselier, P.
    Khalifa, J.
    Thureau, S.
    CANCER RADIOTHERAPIE, 2023, 27 (6-7): : 648 - 652
  • [39] Predictors of Lung Fibrosis after Stereotactic Body Radiation Therapy (SBRT) for Stage I-II Non-Small Cell Lung Cancer (NSCLC)
    Yeh, Norman
    Diot, Quentin
    Altoos, Basel
    Kavanagh, Brian
    Gaspar, Laurie
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S679 - S679
  • [40] Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small cell lung cancer (NSCLC)
    Grills, I. S.
    Mangona, V.
    Welsh, R.
    Chmielewski, G.
    McInerney, E.
    Ye, H.
    Kestin, L. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345